The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Rational Approaches to Improving Selectivity in Drug Design
Open accessAbstract
Appropriate tuning of binding selectivity is a primary objective in the discovery and optimization of a compound on the path toward developing a drug. The environment in which drugs act is complex, with many potential interaction partners. Proteins, DNA, RNA, lipids, sugars, metabolites, and other small molecules all have the potential to interact with a drug, and in many cases these unexpected interactions lead to undesired and often severe side effects. Conversely, the ability to interact with multiple targets or drug resistance mutants can be advantageous in certain contexts. Designing a drug with the appropriate balance of avoidance of undesirable targets (narrow selectivity) and coverage of one or more targets of interest (broad selectivity, also referred to as promiscuity) is a continual drug development challenge. In many cases this objective is attained through trial and error, but there are rational approaches that can guide the tuning of selectivity, and examples have been published that illustrate a number of generalizable strategies. In this review, we discuss fundamental principles that account for selectivity and highlight examples where selectivity has been attained through rational design. An understanding of the general principles that drive selectivity should allow for more efficient design of compounds with desirable selectivity profiles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Goh, K.-I., Cusick, M. E., Valle, D., Childs, B., Vidal, M., & Barabási, A.-L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701361104 · Cited by 3,242
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
A quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Yun, C.-H., Mengwasser, K. E., Toms, A. V., Woo, M. S., Greulich, H., Wong, K.-K., Meyerson, M., & Eck, M. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709662105 · Cited by 2,118
Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects
Sherman, W., Day, T., Jacobson, M. P., Friesner, R. A., & Farid, R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050540c · Cited by 2,031
Self-citationStructural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., iyashiro, J. M., Penning, T. D., Seibert, K., et al. (1996) · Nature · doi:10.1038/384644a0 · Cited by 1,917
Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
Shah, N. P., Tran, C., Lee, F. Y., Chen, P., Norris, D., & Sawyers, C. L. (2004) · Science · doi:10.1126/science.1099480 · Cited by 1,796
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
Schindler, T., Bornmann, W., Pellicena, P., Miller, W. T., Clarkson, B., & Kuriyan, J. (2000) · Science · doi:10.1126/science.289.5486.1938 · Cited by 1,780
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor
Zhang, X., Gureasko, J., Shen, K., Cole, P. A., & Kuriyan, J. (2006) · Cell · doi:10.1016/j.cell.2006.05.013 · Cited by 1,650
Ion-water interaction potentials derived from free energy perturbation simulations
Ȧqvist, J. (1990) · The Journal of Physical Chemistry · doi:10.1021/j100384a009 · Cited by 1,650
Shah, N. P., Nicoll, J. M., Nagar, B., Gorre, M. E., Paquette, R. L., Kuriyan, J., & Sawyers, C. L. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00096-x · Cited by 1,612
Molecular mechanisms that confer antibacterial drug resistance
Walsh, C. (2000) · Nature · doi:10.1038/35021219 · Cited by 1,578
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
The statistical-thermodynamic basis for computation of binding affinities: a critical review
Gilson, M. K., Given, J. A., Bush, B. L., & McCammon, J. A. (1997) · Biophysical Journal · doi:10.1016/s0006-3495(97)78756-3 · Cited by 1,220
Protein Kinase Inhibitors: Insights into Drug Design from Structure
Noble, M. E. M., Endicott, J. A., & Johnson, L. N. (2004) · Science · doi:10.1126/science.1095920 · Cited by 1,198
Multi-target therapeutics: when the whole is greater than the sum of the parts
Zimmermann, G. R., Lehár, J., & Keith, C. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.008 · Cited by 1,105
Rational design of inhibitors that bind to inactive kinase conformations
Liu, Y., & Gray, N. S. (2006) · Nature Chemical Biology · doi:10.1038/nchembio799 · Cited by 1,094
Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
Qian, Z. M., Li, H., Sun, H., & Ho, K. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.561 · Cited by 1,019
Harrington, E. A., Bebbington, D., Moore, J., Rasmussen, R. K., Ajose-Adeogun, A. O., Nakayama, T., Graham, J. A., Demur, C., Hercend, T., Diu-Hercend, A., et al. (2004) · Nature Medicine · doi:10.1038/nm1003 · Cited by 965
Physiochemical drug properties associated with in vivo toxicological outcomes
Hughes, J. D., Blagg, J., Price, D. A., Bailey, S., DeCrescenzo, G. A., Devraj, R. V., Ellsworth, E., Fobian, Y. M., Gibbs, M. E., Gilles, R. W., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.071 · Cited by 946
Ligand Binding: Molecular Mechanics Calculation of the Streptavidin-Biotin Rupture Force
Grubmüller, H., Heymann, B., & Tavan, P. (1996) · Science · doi:10.1126/science.271.5251.997 · Cited by 934
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 877
Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
DiMasi, J. A., Feldman, L., Seckler, A., & Wilson, A. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.295 · Cited by 845
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
Pargellis, C., Tong, L., Churchill, L., Cirillo, P. F., Gilmore, T., Graham, A. G., Grob, P. M., Hickey, E. R., Moss, N., Pav, S., et al. (2002) · Nature Structural Biology · doi:10.1038/nsb770 · Cited by 833
Implications of protein flexibility for drug discovery
Teague, S. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1129 · Cited by 755
Use of an Induced Fit Receptor Structure in Virtual Screening
Sherman, W., Beard, H. S., & Farid, R. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2005.00327.x · Cited by 697
Self-citationAllosteric Modulation of G Protein–Coupled Receptors
May, L. T., Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105159 · Cited by 695
Motifs for molecular recognition exploiting hydrophobic enclosure in protein–ligand binding
Young, T., Abel, R., Kim, B., Berne, B. J., & Friesner, R. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610202104 · Cited by 683
Role of the Active-Site Solvent in the Thermodynamics of Factor Xa Ligand Binding
Abel, R., Young, T., Farid, R., Berne, B. J., & Friesner, R. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja0771033 · Cited by 668
Features of Selective Kinase Inhibitors
Knight, Z. A., & Shokat, K. M. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.04.011 · Cited by 657
Do salt bridges stabilize proteins? A continuum electrostatic analysis
Hendsch, Z. S., & Tidor, B. (1994) · Protein Science · doi:10.1002/pro.5560030206 · Cited by 637
Self-citationRush, T. S., Grant, J. A., Mosyak, L., & Nicholls, A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040163o · Cited by 600
Computations of Standard Binding Free Energies with Molecular Dynamics Simulations
Deng, Y., & Roux, B. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp807701h · Cited by 591
Rapid, electrostatically assisted association of proteins
Schreiber, G., & Fersht, A. R. (1996) · Nature Structural Biology · doi:10.1038/nsb0596-427 · Cited by 559
Straatsma, T. P., & Berendsen, H. J. C. (1988) · The Journal of Chemical Physics · doi:10.1063/1.455539 · Cited by 521
Ladbury, J. E. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90164-7 · Cited by 520
Allosteric inhibition of protein tyrosine phosphatase 1B
Wiesmann, C., Barr, K. J., Kung, J., Zhu, J., Erlanson, D. A., Shen, W., Fahr, B. J., Zhong, M., Taylor, L., Randal, M., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb803 · Cited by 519
Hruby, V. J., al-Obeidi, F., & Kazmierski, W. (1990) · Biochemical Journal · doi:10.1042/bj2680249 · Cited by 518
Probing the links between in vitro potency, ADMET and physicochemical parameters
Gleeson, M. P., Hersey, A., Montanari, D., & Overington, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3367 · Cited by 503
Farid, R., Day, T., Friesner, R. A., & Pearlstein, R. A. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.12.032 · Cited by 502
GRANT, J. A., GALLARDO, M. A., & PICKUP, B. T. (1996) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(19961115)17:14<1653::aid-jcc7>3.0.co;2-k · Cited by 502
Impact of Drug Transporter Studies on Drug Discovery and Development
Mizuno, N., Niwa, T., Yotsumoto, Y., & Sugiyama, Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.1 · Cited by 490
Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
Dobson, P. D., & Kell, D. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2438 · Cited by 475
Can we rationally design promiscuous drugs?
HOPKINS, A., MASON, J., & OVERINGTON, J. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.01.013 · Cited by 469
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
Hauel, N. H., Nar, H., Priepke, H., Ries, U., Stassen, J.-M., & Wienen, W. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0109513 · Cited by 457
Böhm, M., Stürzebecher, J., & Klebe, G. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm981062r · Cited by 439
Roehrig, S., Straub, A., Pohlmann, J., Lampe, T., Pernerstorfer, J., Schlemmer, K.-H., Reinemer, P., & Perzborn, E. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050101d · Cited by 436
The Utility of in Vitro Cytochrome P450 Inhibition Data in the Prediction of Drug-Drug Interactions
Obach, R. S., Walsky, R. L., Venkatakrishnan, K., Gaman, E. A., Houston, J. B., & Tremaine, L. M. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093229 · Cited by 433
Pinto, D. J. P., Orwat, M. J., Koch, S., Rossi, K. A., Alexander, R. S., Smallwood, A., Wong, P. C., Rendina, A. R., Luettgen, J. M., Knabb, R. M., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070245n · Cited by 402
Modeling water molecules in protein-ligand docking using GOLD.
Verdonk, M. L., Chessari, G., Cole, J. C., Hartshorn, M. J., Murray, C. W., Nissink, J. W. M., Taylor, R. D., & Taylor, R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050543p · Cited by 393
Gajiwala, K. S., Wu, J. C., Christensen, J., Deshmukh, G. D., Diehl, W., DiNitto, J. P., English, J. M., Greig, M. J., He, Y.-A., Jacques, S. L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812413106 · Cited by 391
Cavalli, A., Poluzzi, E., De Ponti, F., & Recanatini, M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0208875 · Cited by 382
Annual Reports in Computational Chemistry
(2009) · Annual Reports in Computational Chemistry · doi:10.1016/s1574-1400(09)00513-1 · Cited by 381
Transporter-Mediated Permeation of Drugs Across the Blood–Brain Barrier
Tamai, I., & Tsuji, A. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11<1371::aid-jps1>3.0.co;2-d · Cited by 363
Snyder, P. W., Mecinović, J., Moustakas, D. T., Thomas, S. W., Harder, M., Mack, E. T., Lockett, M. R., Héroux, A., Sherman, W., & Whitesides, G. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114107108 · Cited by 357
Self-citationStructural analysis of the catalytically inactive kinase domain of the human EGF receptor 3
Jura, N., Shan, Y., Cao, X., Shaw, D. E., & Kuriyan, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912101106 · Cited by 338
Inhomogeneous Fluid Approach to Solvation Thermodynamics. 1. Theory
Lazaridis, T. (1998) · The Journal of Physical Chemistry B · doi:10.1021/jp9723574 · Cited by 333
Are buried salt bridges important for protein stability and conformational specificity?
Waldburger, C. D., Schildbach, J. F., & Sauer, R. T. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0295-122 · Cited by 324
Tarek, M., & Tobias, D. J. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76557-x · Cited by 318
Molecular Shape and Medicinal Chemistry: A Perspective
Nicholls, A., McGaughey, G. B., Sheridan, R. P., Good, A. C., Warren, G., Mathieu, M., Muchmore, S. W., Brown, S. P., Grant, J. A., Haigh, J. A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900818s · Cited by 310
BIRB796 Inhibits All p38 MAPK Isoforms in Vitro and in Vivo
Kuma, Y., Sabio, G., Bain, J., Shpiro, N., Márquez, R., & Cuenda, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414221200 · Cited by 304
Bloland, P. B., Lackritz, E. M., Kazembe, P. N., Were, J. B. O., Steketee, R., & Campbell, C. C. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.4.932 · Cited by 287
X-ray Structure of Active Site-inhibited Clotting Factor Xa
Brandstetter, H., Kühne, A., Bode, W., Huber, R., von der Saal, W., Wirthensohn, K., & Engh, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.29988 · Cited by 279
Representing Receptor Flexibility in Ligand Docking through Relevant Normal Modes
Cavasotto, C. N., Kovacs, J. A., & Abagyan, R. A. (2005) · Journal of the American Chemical Society · doi:10.1021/ja042260c · Cited by 278
The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase
Wilson, K. P., McCaffrey, P. G., Hsiao, K., Pazhanisamy, S., Galullo, V., Bemis, G. W., Fitzgibbon, M. J., Caron, P. R., Murcko, M. A., & Su, M. S. S. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90194-0 · Cited by 274
A conserved protonation-dependent switch controls drug binding in the Abl kinase
Shan, Y., Seeliger, M. A., Eastwood, M. P., Frank, F., Xu, H., Jensen, M. Ø., Dror, R. O., Kuriyan, J., & Shaw, D. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811223106 · Cited by 262
Weitz, J. I., Hirsh, J., & Samama, M. M. (2008) · Chest · doi:10.1378/chest.08-0673 · Cited by 262
Michel, J., Tirado-Rives, J., & Jorgensen, W. L. (2009) · Journal of the American Chemical Society · doi:10.1021/ja906058w · Cited by 256
Intracellular pH Sensors: Design Principles and Functional Significance
Srivastava, J., Barber, D. L., & Jacobson, M. P. (2007) · Physiology · doi:10.1152/physiol.00035.2006 · Cited by 250
Sastry, G. M., Dixon, S. L., & Sherman, W. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2002704 · Cited by 244
Self-citationMiyamoto, S., & Kollman, P. A. (1993) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340160303 · Cited by 225
Gouda, H., Kuntz, I. D., Case, D. A., & Kollman, P. A. (2003) · Biopolymers · doi:10.1002/bip.10270 · Cited by 223
Corbeil, C. R., Englebienne, P., & Moitessier, N. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci6002637 · Cited by 215
Transient Pockets on Protein Surfaces Involved in Protein−Protein Interaction
Eyrisch, S., & Helms, V. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070095g · Cited by 213
Gini Coefficient: A New Way To Express Selectivity of Kinase Inhibitors against a Family of Kinases
Graczyk, P. P. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070562u · Cited by 212
Cytochrome P450 in Silico: An Integrative Modeling Approach
de Graaf, C., Vermeulen, N. P. E., & Feenstra, K. A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040180d · Cited by 201
Kufareva, I., & Abagyan, R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8010299 · Cited by 201
Designing substrate specificity by protein engineering of electrostatic interactions.
Wells, J. A., Powers, D. B., Bott, R. R., Graycar, T. P., & Estell, D. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1219 · Cited by 199
Taylor, N. R., Cleasby, A., Singh, O., Skarzynski, T., Wonacott, A. J., Smith, P. W., Sollis, S. L., Howes, P. D., Cherry, P. C., Bethell, R., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9703754 · Cited by 193
Romano, K. P., Ali, A., Royer, W. E., & Schiffer, C. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006370107 · Cited by 189
Kim, Y., Lillo, A. M., Steiniger, S. C. J., Liu, Y., Ballatore, C., Anichini, A., Mortarini, R., Kaufmann, G. F., Zhou, B., Felding-Habermann, B., et al. (2006) · Biochemistry · doi:10.1021/bi060264j · Cited by 187
Prediction of the Water Content in Protein Binding Sites
Michel, J., Tirado-Rives, J., & Jorgensen, W. L. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp9047456 · Cited by 180
AQ4N: a new approach to hypoxia-activated cancer chemotherapy
Patterson, L. H., & McKeown, S. R. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1564 · Cited by 178
The Role of Water Molecules in Computational Drug Design
de Beer, S., Vermeulen, N., & Oostenbrink, C. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790232288 · Cited by 173
Mattevi, A., Fraaije, M. W., Mozzarelli, A., Olivi, L., Coda, A., & van Berkel, W. J. H. (1997) · Structure · doi:10.1016/s0969-2126(97)00245-1 · Cited by 168
Iversen, L. F., Andersen, H. S., Branner, S., Mortensen, S. B., Peters, G. H., Norris, K., Olsen, O. H., Jeppesen, C. B., Lundt, B. F., Ripka, W., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10300 · Cited by 168
Large Neutral Amino Acid Transporter Enables Brain Drug Delivery via Prodrugs
Gynther, M., Laine, K., Ropponen, J., Leppänen, J., Mannila, A., Nevalainen, T., Savolainen, J., Järvinen, T., & Rautio, J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701175d · Cited by 167
Sidhu, R. S., Lee, J. Y., Yuan, C., & Smith, W. L. (2010) · Biochemistry · doi:10.1021/bi1003298 · Cited by 165
Protein Kinase A in Complex with Rho-Kinase Inhibitors Y-27632, Fasudil, and H-1152P
Breitenlechner, C. B., Gaßel, M., Hidaka, H., Kinzel, V., Huber, R., Engh, R. A., & Bossemeyer, D. (2003) · Structure · doi:10.1016/j.str.2003.11.002 · Cited by 162
An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic
Fernández, A., Sanguino, A., Peng, Z., Ozturk, E., Chen, J., Crespo, A., Wulf, S., Shavrin, A., Qin, C., Ma, J., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32373 · Cited by 158
Turning a protein kinase on or off from a single allosteric site via disulfide trapping
Sadowsky, J., Burlingame, M. A., Wolan, D. W., McClendon, C. L., Jacobson, M. P., & Wells, J. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102376108 · Cited by 157
Combating Susceptibility to Drug Resistance
King, N. M., Prabu-Jeyabalan, M., Nalivaika, E. A., & Schiffer, C. A. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.08.010 · Cited by 150
Tochowicz, A., Maskos, K., Huber, R., Oltenfreiter, R., Dive, V., Yiotakis, A., Zanda, M., Bode, W., & Goettig, P. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.068 · Cited by 145
[14] Prediction of binding energetics from structure using empirical parameterization
Baker, B. M., & Murphy, K. P. (1998) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(98)95045-5 · Cited by 144
Kovalevsky, A. Y., Tie, Y., Liu, F., Boross, P. I., Wang, Y., Leshchenko, S., Ghosh, A. K., Harrison, R. W., & Weber, I. T. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050943c · Cited by 140
Factor Xa Inhibitors: Next-Generation Antithrombotic Agents
Pinto, D. J. P., Smallheer, J. M., Cheney, D. L., Knabb, R. M., & Wexler, R. R. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100146h · Cited by 138
Chang, D.-K., Lin, C., Wu, C., & Wu, H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004171 · Cited by 137
Albertella, M. R., Loadman, P. M., Jones, P. H., Phillips, R. M., Rampling, R., Burnet, N. G., Alcock, C., Anthoney, A., Vjaters, E., Dunk, C. R., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4020 · Cited by 131
Heron, N. M., Anderson, M., Blowers, D. P., Breed, J., Eden, J. M., Green, S., Hill, G. B., Johnson, T., Jung, F. H., McMiken, H. H. J., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.11.053 · Cited by 128
Understanding Kinase Selectivity Through Energetic Analysis of Binding Site Waters
Robinson, D. D., Sherman, W., & Farid, R. (2010) · ChemMedChem · doi:10.1002/cmdc.200900501 · Cited by 127
Self-citationThe role of water in sequence-independent ligand binding by an oligopeptide transporter protein
Tame, J. R. H., Sleigh, S. H., Wilkinson, A. J., & Ladbury, J. E. (1996) · Nature Structural Biology · doi:10.1038/nsb1296-998 · Cited by 125
Mechanistic Studies of a Peptidic GRP78 Ligand for Cancer Cell-Specific Drug Delivery
Liu, Y. M., Steiniger, S. C. J., Kim, Y. S., Kaufmann, G. F., Felding‐Habermann, B., & Janda, K. D. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060122j · Cited by 124
Thermodynamic Contributions of the Ordered Water Molecule in HIV-1 Protease
Li, Z., & Lazaridis, T. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0299203 · Cited by 122
Nalam, M. N. L., Ali, A., Altman, M. D., Reddy, G. S., Chellappan, S., Kairys, V., Özen, A., Cao, H., Gilson, M. K., Tidor, B., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02531-09 · Cited by 120
Self-citationDuan, J. J. ‐., Chen, L., Wasserman, Z. R., Lu, Z., Liu, R., Covington, M. B., Qian, M., Hardman, K. D., Magolda, R. L., Newton, R. C., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0255670 · Cited by 120
High‐energy water sites determine peptide binding affinity and specificity of PDZ domains
Beuming, T., Farid, R., & Sherman, W. (2009) · Protein Science · doi:10.1002/pro.177 · Cited by 119
Self-citationRational Methods for the Selection of Diverse Screening Compounds
Huggins, D. J., Venkitaraman, A. R., & Spring, D. R. (2011) · ACS Chemical Biology · doi:10.1021/cb100420r · Cited by 118
Self-citationMeagher, K. L., & Carlson, H. A. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0469378 · Cited by 116
Altman, M. D., Ali, A., Reddy, G. S., Nalam, M. N. L., Anjum, S. G., Cao, H., Chellappan, S., Kairys, V., Fernandes, M. X., Gilson, M. K., et al. (2008) · Journal of the American Chemical Society · doi:10.1021/ja076558p · Cited by 115
Self-citationEfficient Hypoxic Activation of the Anticancer Agent AQ4N by CYP2S1 and CYP2W1
Nishida, C. R., Lee, M., & de Montellano, P. R. O. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065045 · Cited by 115
Han, S., Mistry, A., Chang, J. S., Cunningham, D., Griffor, M., Bonnette, P. C., Wang, H., Chrunyk, B. A., Aspnes, G. E., Walker, D. P., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809038200 · Cited by 110
Dehydron: A Structurally Encoded Signal for Protein Interaction
Fernández, A., & Scott, R. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74619-0 · Cited by 109
Antiangiogenic Targeting Liposomes Increase Therapeutic Efficacy for Solid Tumors
Chang, D.-K., Chiu, C., Kuo, S.-Y., Lin, W.-C., Lo, A., Wang, Y., Li, P., & Wu, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900280200 · Cited by 109
Gynther, M., Ropponen, J., Laine, K., Leppänen, J., Haapakoski, P., Peura, L., Järvinen, T., & Rautio, J. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8015409 · Cited by 106
Thermodynamics of Buried Water Clusters at a Protein−Ligand Binding Interface
Li, Z., & Lazaridis, T. (2005) · The Journal of Physical Chemistry B · doi:10.1021/jp056020a · Cited by 104
Structural and functional analysis of the PDZ domains of human HtrA1 and HtrA3
Runyon, S., Zhang, Y., Appleton, B. A., Sazinsky, S. L., Wu, P., Pan, B., Wiesmann, C., Skelton, N. J., & Sidhu, S. S. (2007) · Protein Science · doi:10.1110/ps.073049407 · Cited by 103
Predicting Binding to P-Glycoprotein by Flexible Receptor Docking
Dolghih, E., Bryant, C., Renslo, A. R., & Jacobson, M. P. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002083 · Cited by 101
Transporter-mediated drug delivery: recent progress and experimental approaches
Sai, Y., & Tsuji, A. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03198-8 · Cited by 101
Frembgen-Kesner, T., & Elcock, A. H. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.03.021 · Cited by 98
Amadasi, A., Spyrakis, F., Cozzini, P., Abraham, D. J., Kellogg, G. E., & Mozzarelli, A. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.01.053 · Cited by 84
Kangas, E., & Tidor, B. (1998) · The Journal of Chemical Physics · doi:10.1063/1.477375 · Cited by 83
Self-citationBottegoni, G., Kufareva, I., Totrov, M. M., & Abagyan, R. A. (2008) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-008-9188-5 · Cited by 83
Liu, F., Boross, P. I., Wang, Y.-F., Tőzsér, J., Louis, J. M., Harrison, R. W., & Weber, I. T. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.095 · Cited by 82
Scheffzek, K., Kliche, W., Wiesmüller, L., & Reinstein, J. (1996) · Biochemistry · doi:10.1021/bi960642s · Cited by 82
A cell-penetrating peptidic GRP78 ligand for tumor cell-specific prodrug therapy
Yoneda, Y., Steiniger, S. C. J., Čapková, K., Mee, J. M., Liu, Y. M., Kaufmann, G. F., & Janda, K. D. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.060 · Cited by 77
Energy calculations and analysis of HIV-1 protease-inhibitor crystal structures
Gustchina, A., Sansom, C., Prévost, M., et al. (1994) · Protein Engineering Design and Selection · doi:10.1093/protein/7.3.309 · Cited by 73
Role of Water in Molecular Docking Simulations of Cytochrome P450 2D6
Santos, R., Hritz, J., & Oostenbrink, C. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900293e · Cited by 71
Structural and functional analysis of the ligand specificity of the HtrA2/Omi PDZ domain
Zhang, Y., Appleton, B. A., Wu, P., Wiesmann, C., & Sidhu, S. S. (2007) · Protein Science · doi:10.1110/ps.072833207 · Cited by 68
Schubert, C., Schalk‐Hihi, C., Struble, G. T., Ma, H., Petrounia, I. P., Brandt, B., Deckman, I. C., Patch, R. J., Player, M. R., Spurlino, J. C., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608183200 · Cited by 66
Investigation of the Relationship between Topology and Selectivity for Druglike Molecules
Yang, Y., Chen, H., Nilsson, I., Mureşan, S., & Engkvist, O. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1008456 · Cited by 63
IK682, a tight binding inhibitor of TACE
Niu, X., Umland, S. P., Ingram, R. N., Beyer, B. M., Liu, Y., Sun, J., Lundell, D. J., & Orth, P. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.03.034 · Cited by 57
Thermodynamic Properties of Water Molecules at a Protein–Protein Interaction Surface
Huggins, D. J., Marsh, M., & Payne, M. C. (2011) · Journal of Chemical Theory and Computation · doi:10.1021/ct200465z · Cited by 55
Self-citationEvaluation of the substrate envelope hypothesis for inhibitors of HIV‐1 protease
Chellappan, S., Kairys, V., Fernandes, M. X., Schiffer, C. A., & Gilson, M. K. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21431 · Cited by 54
Electrostatic specificity in molecular ligand design
Kangas, E., & Tidor, B. (2000) · The Journal of Chemical Physics · doi:10.1063/1.481522 · Cited by 53
Self-citationAnalysis of Kinase Inhibitor Selectivity using a Thermodynamics-Based Partition Index
Cheng, A. C., Eksterowicz, J. E., Geuns-Meyer, S. D., & Sun, Y. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100301x · Cited by 52
Protein Kinase Inhibitors: Structural Insights Into Selectivity
Thaimattam, R., Banerjee, R., Miglani, R., & Javed Iqbal, M. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207781757042 · Cited by 52
Charge optimization leads to favorable electrostatic binding free energy
Kangas, E., & Tidor, B. (1999) · Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics · doi:10.1103/physreve.59.5958 · Cited by 51
Self-citationDecomposing the Energetic Impact of Drug Resistant Mutations in HIV-1 Protease on Binding DRV
Cai, Y., & Schiffer, C. A. (2010) · Journal of Chemical Theory and Computation · doi:10.1021/ct9004678 · Cited by 45
Green, D. F., Dennis, A. T., Fam, P. S., Tidor, B., & Jasanoff, A. (2006) · Biochemistry · doi:10.1021/bi060857u · Cited by 43
Self-citationMarco, E., & Gago, F. (2007) · ChemMedChem · doi:10.1002/cmdc.200700087 · Cited by 43
Tian, F., Li, Y., Lv, F., Luo, X., & Pan, Y. (2010) · Amino Acids · doi:10.1007/s00726-010-0661-9 · Cited by 40
Action‐at‐a‐distance interactions enhance protein binding affinity
Joughin, B. A., Green, D. F., & Tidor, B. (2005) · Protein Science · doi:10.1110/ps.041283105 · Cited by 39
Self-citationRadhakrishnan, M. L., & Tidor, B. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp074285e · Cited by 39
Self-citationComputational Approaches to Model Ligand Selectivity in Drug Design
Ortiz, A., Gómez‐Puertas, P., Leo‐Macías, A., López‐Romero, P., López‐Viñas, E., Morreale, A., Murcia, M., & Wang, K. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606775193338 · Cited by 39
Fritz, T. A., Tondi, D., Finer-Moore, J. S., Costi, M. P., & Stroud, R. M. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00067-9 · Cited by 32
Charge Optimization Increases the Potency and Selectivity of a Chorismate Mutase Inhibitor
Mandal, A., & Hilvert, D. (2003) · Journal of the American Chemical Society · doi:10.1021/ja029447t · Cited by 29
Optimal Charges in Lead Progression: A Structure-Based Neuraminidase Case Study
Armstrong, K. A., Tidor, B., & Cheng, A. C. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051105l · Cited by 29
Self-citationHuggins, D. J., McKenzie, G. J., Robinson, D. D., Narvaez, A. J., Hardwick, B. S., Roberts-Thomson, M., Venkitaraman, A. R., Grant, G. H., & Payne, M. C. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000880 · Cited by 29
Self-citationNovel Method for Probing the Specificity Binding Profile of Ligands: Applications to HIV Protease
Sherman, W., & Tidor, B. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00659.x · Cited by 28
Self-citationA Highly Selective Oligopeptide Binding Protein from the Archaeon Sulfolobus Solfataricus
Gogliettino, M., Balestrieri, M., Pòcsfalvi, G., Fiume, I., Natale, L., Rossi, M., & Palmieri, G. (2010) · Journal of Bacteriology · doi:10.1128/jb.01414-09 · Cited by 24
Conformational selection in silico: Loop latching motions and ligand binding in enzymes
Wong, S., & Jacobson, M. P. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21666 · Cited by 24
Profiling Charge Complementarity and Selectivity for Binding at the Protein Surface
Sulea, T. I., & Purisima, E. O. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)70016-2 · Cited by 23
Lopes, A., Busch, M. S. A., & Simonson, T. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21414 · Cited by 20
Lao, B. J., & Kamei, D. T. (2007) · Biotechnology Progress · doi:10.1021/bp070080b · Cited by 15
Geroult, S., Virdee, S., & Waksman, G. (2005) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2005.00315.x · Cited by 11
Cited by
Molecular Recognition in Chemical and Biological Systems
Persch, E., Dumele, O., & Diederich, F. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201408487 · Cited by 654
Karimi, M., Wu, D., Wang, Z., & Shen, Y. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz111 · Cited by 536
Caenepeel, S., Brown, S. P., Belmontes, B., Moody, G., Keegan, K. S., Chui, D., Whittington, D. A., Huang, X., Poppe, L., Cheng, A. C., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0387 · Cited by 432
Predictions of Ligand Selectivity from Absolute Binding Free Energy Calculations
Aldeghi, M., Heifetz, A., Bodkin, M. J., Knapp, S., & Biggin, P. C. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b11467 · Cited by 177
Millan, M. J., Goodwin, G. M., Meyer-Lindenberg, A., & Ove Ögren, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.016 · Cited by 132
Metadata
- Authors
- Huggins, D. J., Sherman, W., & Tidor, B.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-01-12
- Volume
- 55
- Issue
- 4
- Pages
- 1424-1444
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W141181845
- Cited by
- 367
- References
- 157
- FWCI
- 20.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.